May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?

Detalles Bibliográficos
Autores principales: Scicali, Roberto, Di Pino, Antonino, Piro, Salvatore, Rabuazzo, Agata M., Purrello, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217767/
https://www.ncbi.nlm.nih.gov/pubmed/32405159
http://dx.doi.org/10.1016/j.numecd.2020.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217767/
https://www.ncbi.nlm.nih.gov/pubmed/32405159
http://dx.doi.org/10.1016/j.numecd.2020.05.003

Ejemplares similares